Interestingly, the epidermal growth factor receptor (EGFR), an important pathway in HNSCC and current target for treatment [39], and Wnt signaling pathways have potential crosstalk via β-catenin [40]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.